½Ã°£ °­ÀÇ½Ç °­ÀÇ Á¦¸ñ ¿¬ÀÚ / ¼Ò¼Ó
08:00 - 08:30 µî ·Ï
08:30 - 08:40 Room I °³ ȸ »ç ´ëÇѳ»ºÐºñÇÐȸ ȸÀå
08:40 - 10:10 Room I ½Å°æ³»ºÐºñ¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÂÀå: ÃÖ¿µ±æ, ±è¼±¿ì
¸»´Üºñ´ëÁõÀÇ ÃֽŠġ·á Feng Gu(Peking Union Medical college, China)
¸»´Üºñ´ëÁõ µî·Ï»ç¾÷ º¸°í ¼Û¿µµæ(Àϻ꺴¿ø)
¸»´Üºñ´ëÁõ ÀÓ»óÁø·áÁöħ È«Àº°æ(ÇѸ²ÀÇ´ë)
Room II Çп¬»ê ½ÉÆ÷Áö¾ö¥°- CPC ÁÂÀå: ¼ÕÈ£»ó
³»ºÐºñ³»°ú ÀÌ¿µ½Ç(µ¿±¹ÀÇ´ë)
¿µ»ó(ÇÙÀÇÇаú) ±èÀÎÁÖ(ºÎ»êÀÇ´ë)
Çغκ´¸®°ú ±Ç¼±¿µ(°è¸íÀÇ´ë)
10:10 - 10:30 Coffee Break
10:30 - 11:30 Room I Hot Topics in Endocrinology ÁÂÀå: ±è±â¼ö, ±è´ö±Ô
Ä®½· Ä¡·á - cons ¹Î¿ë±â(¼º±Õ°üÀÇ´ë)
Ä®½· Ä¡·á - pros Á¤È£¿¬(°æÈñÀÇ´ë)
¹æ»ç¼±°ú °©»ó¼± ÀÌ°¡Èñ(¼­¿ïÀÇ´ë)
Room II Çп¬»ê ½ÉÆ÷Áö¾ö¥± -Information technology ÁÂÀå: ¿ø±ÔÀå, ±èÁ¤±¹
Social producing and networking¿¡ ±â¹ÝÇÑ Digital Lab noteÀÇ ¼Ò°³¿Í È°¿ë Á¶ÀçÇü(°¡Å縯ÀÇ´ë)
À¯Àüü µ¥ÀÌÅÍÀÇ °Ë»ö ¹× È°¿ë À¯¿õ½Ä(°¡ÃµÀÇ´ë)
°­ÀÇ¿Í ¿¬±¸¸¦ À§ÇÑ ÀÇÇÐÀÚ·á °Ë»ö°ú »ç¿ë Ãְ湬(°í·ÁÀÇ´ë)
11:30 - 12:40 Room I Luncheon Lecture I ÁÂÀå: ±è±¤¿ø
The effective management of type 2 diabetes for patients care with GLP-1 agonist Á¶ÀçÇü(°¡Å縯ÀÇ´ë)
Room II Luncheon Lecture II ÁÂÀå: ÀÌÇöö
»õ·Î¿î ´ç´¢º´ ¿ëÁ¦ ±Þ¿©±âÁØ¿¡ µû¸¥ ȯÀÚ Ä¡·á Àü·« ¿À½ÂÁØ(°æÈñÀÇ´ë)
12:40 - 13:30 Room I Plenary Lecture I ÁÂÀå: °­¹«ÀÏ
Osteoclast activity and subtypes as a function of physiology and pathology Kim Henriksen
(Nordic Bioscience, Denmark)
13:30 - 14:10 Room I Ư°­ ÁÂÀå: ÃÖÁ¦¿ë
´ë±¸°æºÏ÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´ÜÀÇ ½Å¾à°³¹ßÁö¿ø¼¾ÅÍÀÇ ¿ªÇÒ À±¼®±Õ
(´ë±¸°æºÏ÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü)
R1(B1, Jade Hall) MTE : ´ç´¢º´È¯ÀÚÀÇ ´ë»çÁõÈıº Ä¡·á ¿ÀűÙ(ÃæºÏÀÇ´ë)
R2(2F, Ruby) MTE : °ñ´Ù°øÁõ Ä¡·á¾àÁ¦ ¼±Åà ¹× »õ·Î¿î ¾à¹°Ä¡·áÁ¦ Çѱâ¿Á(°üµ¿ÀÇ´ë)
R3((2F, Emerald) MTE : DTC ȯÀÚ¿¡¼­ÀÇ Tg ³óµµ: ¾î¶»°Ô Çؼ®Çϳª? ±è¿ø¹è(¿ï»êÀÇ´ë)
R4(2F, Maple) MTE : Current lipid treatment guideline - ESC/EAS guideline ±è¼º·¡(°¡Å縯ÀÇ´ë)
R5(2F, Opal) MTE : Adrenal function test ±èµÎ¸¸(ÇѸ²ÀÇ´ë)
R6(2F, Sapphire) MTE: ±âÃÊÀÇÇÐÀº ½Å¼¼°è·Î °¡´Â ±æÀ̾ú´Ù ¹Ú»óö(°¡ÃµÀÇ´ë)
14:10 - 14:30 Coffee Break
14:30 - 16:00 Room I Symposium - DM ¨Ï (Cardiovascular aspect of diabetes) ÁÂÀå: Â÷ºÀ¼ö, Ãְ湬
Vascular calcification and OPG/RANKL axis in diabetes ÀÌ¿ø¿µ(¼º±Õ°üÀÇ´ë)
Cardio-ankle vascular index and microvascular complications in T2DM À̺´¿Ï(¿¬¼¼ÀÇ´ë)
Cardiovascular autonomic dysfunction in patients with T2DM °í½ÂÇö(°¡Å縯ÀÇ´ë)
Room II Çп¬»ê ½ÉÆ÷Áö¾ö¥² - DM(1) ÁÂÀå: ¹Ú°æ¼ö, ¾È±ÔÁ¤
Current state of type 1 diabetes immunotherapy ±èÀçÇö(¼º±Õ°üÀÇ´ë)
Anti-VEGF therapy for diabetic retinopathy º¯¼®È£(¿¬¼¼ÀÇ´ë ¾È°ú)
Anti-RAGE therapy for diabetes and its complication ¹Ú¿µ¿ì(Çѱ¹»ý¸í°øÇבּ¸¿ø)
16:00 - 17:30 Room I Symposium - Bone ¨Ï (Hot issues in osteoporosis) ÁÂÀå: À±Çö±¸, º¯µ¿¿ø
Biochemical markers of extracellular matrix remodeling Kim Henriksen
(Nordic Bioscience, Denmark)
Vitamin D and sarcopenia ¿À±â¿ø(¼º±Õ°üÀÇ´ë)
Sclerostin and bone - clinical perspectives °íÁ¤¹Î(¿ï»êÀÇ´ë)
Room II Çп¬»ê ½ÉÆ÷Áö¾ö ¥³ - DM(2) ÁÂÀå: ¼ÕÇö½Ä, ±èöÈñ
Incretin(Gut hormone) and insulin secretion & action Á¶¿µ¹Î(¼­¿ïÀÇ´ë)
Development of long acting analogue of GLP-1 ¼ÕÁö¿õ(Çѹ̾àÇ°)
Molecular anlysis of microbial community in GI tract ¹èÁø¿ì(°æÈñ´ë »ý¹°Çаú)
¨Ï Clinical, ¨à Translational, ¨Î Basic


½Ã°£ °­ÀÇ½Ç °­ÀÇ Á¦¸ñ ¿¬ÀÚ / ¼Ò¼Ó
07:00 - 07:30 Room I Breakfast Symposium ÁÂÀå: Â÷ºÀ¿¬
Novel Strategies for Better Management of DM Patients with New Partner Â÷ºÀ¼ö(¿¬¼¼ÀÇ´ë)
07:40 - 08:00 µî ·Ï
08:00 - 09:00 Room I Clinical Update (Recent clinical practice guidelines for the management of diabetes mellitus) ÁÂÀå: ÀÌÇü¿ì, ¹Úż±
Type 2 diabetes in pregnancy ±è¼ºÈÆ(°üµ¿ÀÇ´ë)
Management of hospital patients with diabetes mellitus ÀÌÀçÇõ(°üµ¿ÀÇ´ë)
Primary prevention of cardiovascular disease in patients with type 2 diabetes À¯¼ºÈÆ(ÇѸ²ÀÇ´ë)
Room II Symposium - Neuroendo ¨à¨Î (Circadian regulation of enegy metabolism) ÁÂÀå: À¯°æÀÚ
Role of Nampt in hypothalamic NAD biology and circadian control of metabolism ±è¹Î¼±(¿ï»êÀÇ´ë)
Nuclear Hormone Receptors Regulate Metabolism and Cancer David Moore(Baylor College of Medicine, USA)
09:00 - 09:20 Coffee Break
09:20 - 10:50 Room I Symposium - Thyroid ¨Ï (New perspective of thyroid cancer) ÁÂÀå: ¼Û¿µ±â, Á¤ÀçÈÆ
The Bethesda classification system for reporting thyroid FNA ¹Ú¼Ò¿¬(¼­¿ïÀÇ´ë, º´¸®Çаú)
°©»ó¼±¾Ï ¼ö¼úÈÄ ÃÊÀ½ÆÄ°Ë»çÀÇ ¿ªÇÒ ¹éÁ¤È¯(¿ï»êÀÇ´ë, ¿µ»óÀÇÇаú)
Advanced papillary thyroid cancer in TNM stage IV : clinical and angio-oncogenesis studies Jen-der Lin(Chang Gung Univ., Taiwan)
Room II Symposium - Lipid & Obesity ¨à¨Î (Ectopic fat accumulation and organ dysfunction) ÁÂÀå: °­¼º±¸, Â÷ºÀ¿¬
Pancreas ¿ø±ÔÀå(¿µ³²ÀÇ´ë)
Liver ÀÌÀαÔ(°æºÏÀÇ´ë)
Skeletal muscle ÃÖö¼ö(°¡ÃµÀÇ´ë)
10:50 - 11:30 Room I ³²°îÇмú»ó ½Ã»ó ¹× ¹ßÇ¥ ÁÂÀå: ¹ÎÇå±â
³úÇϼöü Á¾¾çÀÇ º´Àΰú ½Å¾à °³¹ß ÀÌÀºÁ÷(¿¬¼¼ÀÇ´ë)
11:30 - 12:40 Room I Luncheon Lecture III ÁÂÀå : ±èÁø¿ì
Proactive strategy of multidisciplinary risk intervention for diabetic patients ±èÁ¾È­(¼¼Á¾º´¿ø)
Reappraisal of Calcium-channel blocker for diabetic patients Á¤Àΰæ(°æÈñÀÇ´ë)
Room II Luncheon Lecture IV ÁÂÀå : À̹®±Ô
Ç÷´ç Á¶Àý¿¡ À־ Resistant starch ¿Í voglibose ÀÇ À¯¿ë¼º ±èµÎ¸¸(ÇѸ²ÀÇ´ë)
12:40 - 13:10 Topaz Hall Poster Session
13:10 - 14:00 Room I Plenary Lecture II ÁÂÀå: ±è±¤¿ø
Nuclear receptors and diabetes : McGarry was right David Moore(Baylor College of Medicine, USA)
14:00 - 14:30 Room I Presidential Lecture
Diabetic Nephropathy: A glimpse of pathophysiological mechanisms ±èÅÂÈ­(´ëÇѳ»ºÐºñÇÐȸ ȸÀå)
14:30 - 14:50 Coffee Break
14:50 - 16:20 Room I Symposium - Bone ¨à¨Î ÁÂÀå: Çѱâ¿Á, ±èÀÎÁÖ
Interrelationship of Runx2 and estrogen pathway in skeleltal tissues ÃÖÁ¦¿ë(°æºÏÀÇ´ë »ýÈ­Çб³½Ç)
Reciprocal regulation of bone mass and fat mass ½ÅÂù¼ö(¼­¿ïÀÇ´ë)
cAMP pathway and bone metabolism ±èÈ«Èñ(¼­¿ï´ë Ä¡´ë)
Room II Symposium - Thyroid ¨à¨Î (Recent advance in thyroid research) ÁÂÀå: ¹ÚµµÁØ, ¼Û¹ÎÈ£
Feedback regulation in targeted therapy for thyroid cancer °íÀ±¿ì(¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú)
Role of RAS system in hyperthyroid cardiomyopathy ±èº¸Çö(ºÎ»êÀÇ´ë)
Mechanism of radioiodine resistance of differentiated thyroid carcinoma ±è¼±¿í(¼º±Õ°üÀÇ´ë)
16:20 - 16:30 Room I 2011³âµµ ±¹³»/¿Ü Çмú»ó, ¿ì¼öÆ÷½ºÅÍ ½Ã»ó½Ä
16:30 - 16:40 Room I Æó ȸ »ç ±è¼º¿î(´ëÇѳ»ºÐºñÇÐȸ ÀÌ»çÀå)
¨Ï Clinical, ¨à Translational, ¨Î Basic



1